Kyrgyzstan Fines Pharmaceutical Sector 2.34 Million Som in Six Months

Kyrgyzstan has levied fines amounting to 2.34 million som against entities involved in pharmaceutical activities and healthcare organizations during the first six months of 2026. The Ministry of Health announced the penalties following extensive inspections aimed at ensuring compliance with regulations governing medicines and medical devices.

The majority of the fines, 1.765 million som, were imposed on pharmaceutical businesses for various breaches. An additional 575,000 som were levied against healthcare organizations. These penalties underscore ongoing challenges in maintaining strict standards within the country's pharmaceutical sector.

Key violations identified during the inspections included inadequate storage conditions for medications and medical supplies, the use of non-standard prescription forms, and breaches of ethical marketing guidelines. These issues highlight critical areas requiring immediate attention and corrective action to safeguard public health and ensure the integrity of pharmaceutical practices in Kyrgyzstan.